These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 20817723)
61. Alternative splicing variants of IRF-1 lacking exons 7, 8, and 9 in cervical cancer. Lee EJ; Jo M; Park J; Zhang W; Lee JH Biochem Biophys Res Commun; 2006 Sep; 347(4):882-8. PubMed ID: 16857162 [TBL] [Abstract][Full Text] [Related]
62. SUMOylated IRF-1 shows oncogenic potential by mimicking IRF-2. Park SM; Chae M; Kim BK; Seo T; Jang IS; Choi JS; Kim IC; Lee JH; Park J Biochem Biophys Res Commun; 2010 Jan; 391(1):926-30. PubMed ID: 19962964 [TBL] [Abstract][Full Text] [Related]
63. Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding. Eason DD; Shepherd AT; Blanck G Biochim Biophys Acta; 1999 Jul; 1446(1-2):140-4. PubMed ID: 10395927 [TBL] [Abstract][Full Text] [Related]
64. HIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation. Remoli AL; Marsili G; Perrotti E; Acchioni C; Sgarbanti M; Borsetti A; Hiscott J; Battistini A mBio; 2016 Oct; 7(5):. PubMed ID: 27795392 [TBL] [Abstract][Full Text] [Related]
65. Functional relevance of the IRF-1 promoter polymorphism rs2549009 on transcriptional activity in a native genomic environment. Mertens J; Ramadori G; Mihm S Hum Mol Genet; 2010 Dec; 19(23):4587-94. PubMed ID: 20846942 [TBL] [Abstract][Full Text] [Related]
66. A model of the three-dimensional structure of human interferon responsive factor 1 and its modifications upon phosphorylation or phosphorylation-mimicking mutations. Storchi L; Remoli AL; Marsili G; Acchioni C; Acchioni M; Battistini A; Sgarbanti M; Marrone A J Biomol Struct Dyn; 2019 Oct; 37(17):4632-4643. PubMed ID: 30569833 [TBL] [Abstract][Full Text] [Related]
67. PU.1, interferon regulatory factor (IRF) 2, and the interferon consensus sequence-binding protein (ICSBP/IRF8) cooperate to activate NF1 transcription in differentiating myeloid cells. Huang W; Horvath E; Eklund EA J Biol Chem; 2007 Mar; 282(9):6629-43. PubMed ID: 17200120 [TBL] [Abstract][Full Text] [Related]
68. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells. Stang MT; Armstrong MJ; Watson GA; Sung KY; Liu Y; Ren B; Yim JH Oncogene; 2007 Sep; 26(44):6420-30. PubMed ID: 17452973 [TBL] [Abstract][Full Text] [Related]
69. Promoter organization of the interferon-A genes differentially affects virus-induced expression and responsiveness to TBK1 and IKKepsilon. Civas A; Génin P; Morin P; Lin R; Hiscott J J Biol Chem; 2006 Feb; 281(8):4856-66. PubMed ID: 16380379 [TBL] [Abstract][Full Text] [Related]
77. Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors. Sharf R; Azriel A; Lejbkowicz F; Winograd SS; Ehrlich R; Levi BZ J Biol Chem; 1995 Jun; 270(22):13063-9. PubMed ID: 7768900 [TBL] [Abstract][Full Text] [Related]
78. Functional dissection of the transactivation domain of interferon regulatory factor-1. Kim EJ; Park CH; Park JS; Um SJ Biochem Biophys Res Commun; 2003 May; 304(2):253-9. PubMed ID: 12711307 [TBL] [Abstract][Full Text] [Related]
79. Active repression of IFN regulatory factor-1-mediated transactivation by IFN regulatory factor-4. Yoshida K; Yamamoto K; Kohno T; Hironaka N; Yasui K; Kojima C; Mukae H; Kadota J; Suzuki S; Honma K; Kohno S; Matsuyama T Int Immunol; 2005 Nov; 17(11):1463-71. PubMed ID: 16172134 [TBL] [Abstract][Full Text] [Related]